Error: Could not add to watchlist. X
+ Watchlist

Transition Therapeutics Inc

TTH:CN
Acquired
TTH:CN was acquired by OPK:US
CAD
Volume
0
52Wk Range
0.89 - 2.38
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
52Wk Range
0.89 - 2.38
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-0.64
Market Cap (CAD)
-
Shares Outstanding (m)
38.799
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.83%
% Price Change
-1.07%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.
Address
101 College Street
Suite 220
Toronto, ON M5G 1L7
Canada
Phone
1-416-260-7770
Show More